Chun-Hsiang Chiu

814 total citations
35 papers, 578 citations indexed

About

Chun-Hsiang Chiu is a scholar working on Molecular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Chun-Hsiang Chiu has authored 35 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Medicine, 12 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Chun-Hsiang Chiu's work include Antibiotic Resistance in Bacteria (13 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and COVID-19 Clinical Research Studies (6 papers). Chun-Hsiang Chiu is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and COVID-19 Clinical Research Studies (6 papers). Chun-Hsiang Chiu collaborates with scholars based in Taiwan. Chun-Hsiang Chiu's co-authors include Hsin-Chieh Hsu, Wen‐Tien Tsai, Kuo-Jong Hsien, Ya‐Sung Yang, Feng‐Yee Chang, Jung‐Chung Lin, Yung-Chih Wang, Kuo‐Ming Yeh, Chien‐Ming Lin and Shu‐Chen Kuo and has published in prestigious journals such as Bioresource Technology, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Chun-Hsiang Chiu

32 papers receiving 563 citations

Peers

Chun-Hsiang Chiu
Abdelraouf A. Elmanama Palestinian Territory
Chun-Hsiang Chiu
Citations per year, relative to Chun-Hsiang Chiu Chun-Hsiang Chiu (= 1×) peers Abdelraouf A. Elmanama

Countries citing papers authored by Chun-Hsiang Chiu

Since Specialization
Citations

This map shows the geographic impact of Chun-Hsiang Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun-Hsiang Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun-Hsiang Chiu more than expected).

Fields of papers citing papers by Chun-Hsiang Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun-Hsiang Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun-Hsiang Chiu. The network helps show where Chun-Hsiang Chiu may publish in the future.

Co-authorship network of co-authors of Chun-Hsiang Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Chun-Hsiang Chiu. A scholar is included among the top collaborators of Chun-Hsiang Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun-Hsiang Chiu. Chun-Hsiang Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, C.C., Chun-Hsiang Chiu, Te‐Yu Lin, & Feng‐Yee Chang. (2025). Severe SARS-CoV-2 alpha variant convalescent patients exhibit worse T cell immune response than those with mild severity disease. Journal of the Formosan Medical Association. 125(3). 338–344.
3.
4.
Chung, Hsing‐Yi, Chih‐Kai Chang, Hung‐Hsin Lin, et al.. (2024). Artificial intelligence-clinical decision support system for enhanced infectious disease management: Accelerating ceftazidime-avibactam resistance detection in Klebsiella pneumoniae. Journal of Infection and Public Health. 17(10). 102541–102541. 4 indexed citations
5.
Wang, Yung-Chih, Li-Chen Yen, Yao‐Wen Chang, et al.. (2023). SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19. Infection. 52(3). 955–983. 9 indexed citations
6.
Chiu, Chun-Hsiang, Feng‐Yee Chang, Yi‐Jen Hung, et al.. (2022). Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities. Frontiers in Cellular and Infection Microbiology. 12. 862656–862656. 6 indexed citations
7.
Hsu, Wei-Ting, Chun-Hsiang Chiu, Feng‐Yee Chang, et al.. (2021). An Integrated Platform for Serological Detection and Vaccination of COVID-19. Frontiers in Immunology. 12. 771011–771011. 5 indexed citations
8.
Lee, Yi‐Tzu, Jun‐Ren Sun, Yung-Chih Wang, et al.. (2020). Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment. International Journal of Antimicrobial Agents. 55(6). 105956–105956. 6 indexed citations
9.
Tsai, Chun-Chou, Yung-Chih Wang, Chun-Hsiang Chiu, et al.. (2020). Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan. Journal of the Formosan Medical Association. 120(1). 713–719. 3 indexed citations
10.
Chiu, Chun-Hsiang, Ying-Chuan Wang, Kuo‐Ming Yeh, et al.. (2016). Influence of ethanol concentration in the phagocytic function of neutrophils against Klebsiella pneumoniae isolates in an experimental model. Journal of Microbiology Immunology and Infection. 51(1). 64–69. 9 indexed citations
11.
Chiu, Chun-Hsiang, Yuhan Liu, Yung-Chih Wang, et al.. (2016). In vitroactivity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D β-lactamase-producingAcinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 71(12). 3441–3448. 7 indexed citations
12.
Yang, Ya‐Sung, Chun-Hsiang Chiu, Ti Yin, et al.. (2015). Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure. Clinical Microbiology and Infection. 21(8). 758–764. 12 indexed citations
13.
Yang, Ya‐Sung, Yi‐Tzu Lee, Yung-Chih Wang, et al.. (2015). Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan. Infection Genetics and Evolution. 31. 305–311. 8 indexed citations
14.
Chiu, Chun-Hsiang, Yi‐Tzu Lee, Yung-Chih Wang, et al.. (2015). A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infectious Diseases. 15(1). 400–400. 21 indexed citations
15.
Lin, Hsin‐An, Ya‐Sung Yang, Hsin‐Chung Lin, et al.. (2015). Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. Journal of Microbiology Immunology and Infection. 49(2). 237–242. 14 indexed citations
16.
Wang, Ying-Chuan, et al.. (2013). Scrub Typhus Cases in a Teaching Hospital in Penghu, Taiwan, 2006–2010. Vector-Borne and Zoonotic Diseases. 13(3). 154–159. 14 indexed citations
17.
Wang, Yung-Chih, Ning‐Chi Wang, Jung‐Chung Lin, et al.. (2011). Risk factors and outcomes of cytomegalovirus viremia in cancer patients: A study from a medical center in northern Taiwan. Journal of Microbiology Immunology and Infection. 44(6). 442–448. 17 indexed citations
18.
Chiu, Chun-Hsiang, Kuo‐Ming Yeh, L. Kristopher Siu, et al.. (2011). Impact of age on neutrophil phagocytic reaction with different capsular serotypes of Klebsiella pneumoniae. Journal of Microbiology Immunology and Infection. 44(5). 333–337. 6 indexed citations
19.
20.
Yang, Ya‐Sung, Chih‐Hung Ku, Jung‐Chung Lin, et al.. (2010). Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections. Journal of Microbiology Immunology and Infection. 43(3). 194–199. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026